Hims & Hers stock rallies amidst increased revenue, GLP-1 generic announcement
Direct-to-consumer virtual care company Hims & Hers Health reported a 77% year-over-year increase in revenue from $226.7 million in the third quarter of 2023 to $401.6 million in Q3 2024. The San Francisco-based company reported…
Continue Reading